Menu

• Ask a Health Expert about EOSINOPHIL PERCENTAGE INCREASED
• Post Your Side Effect related to EOSINOPHIL PERCENTAGE INCREASED
• EOSINOPHIL PERCENTAGE INCREASED and FDA Warnings
• EOSINOPHIL PERCENTAGE INCREASED in Patients Wiki
• Report EOSINOPHIL PERCENTAGE INCREASED in Drug Side Effect Survey

EOSINOPHIL PERCENTAGE INCREASED side effect

What is EOSINOPHIL PERCENTAGE INCREASED ?

A Health Expert wants to answer your question. Please provide details below.

Type your question here

 letters left

Tazocin Side Effects Report #5671966-7
Health Professional from JAPAN reported TAZOCIN problem on Mar 12, 2008. Female patient, weighting 121.3 lb, was diagnosed with cholecystitis, fluid replacement, nutritional support and was treated with TAZOCIN. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, interstitial lung disease, . TAZOCIN dosage: unknown. During the same period patient was treated with ELECTROLYTE SOLUTIONS, VITAMINS NOS, ASCORBIC ACID, RIBOFLAVIN, THIAMINE DISULFIDE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B. Patient was hospitalized. Patient recovered.

Tazocin Side Effects Report #5627413-4
TAZOCIN problem was reported by a Health Professional from JAPAN on Feb 08, 2008. Female patient, weighting 121.3 lb, was diagnosed with cholecystitis and was treated with TAZOCIN. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, interstitial lung disease, . TAZOCIN dosage: unknown. During the same period patient was treated with ELECTROLYTE SOLUTIONS, VITAMINS NOS, ASCORBIC ACID, RIBOFLAVIN, THIAMINE DISULFIDE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B. Patient was hospitalized. Patient recovered.

Citalopram Side Effects Report #5642290-3
Consumer or non-health professional from GERMANY reported CITALOPRAM HYDROBROMIDE problem on Feb 11, 2008. Female patient, 21 years of age, was treated with CITALOPRAM HYDROBROMIDE. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, hypersensitivity, leukopenia, neutrophil count decreased, platelet count decreased, rash macular, treatment noncompliance, viral infection, . CITALOPRAM HYDROBROMIDE dosage: 20 MG QD PO. During the same period patient was treated with CITALOPRAM HYDROBROMIDE, LAMICTAL. Patient was hospitalized. Patient recovered.

Lansoprazole Side Effects Report #5613994-3
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Jan 23, 2008. Male patient, 84 years of age, was diagnosed with gastric haemorrhage and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, . LANSOPRAZOLE dosage: 15 MG (15 MG, 1 IN 1 D) PER ORAL. During the same period patient was treated with FULCALIQ 2, MINERALIN, LASIX. Patient died.


Namenda Side Effects Report #5590861-5
Health Professional from UNITED STATES reported NAMENDA problem on Oct 18, 2006. Female patient, 84 years of age, was diagnosed with dementia alzheimer's type and was treated with NAMENDA. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, ileus, lymphocyte percentage decreased, rash pruritic, red blood cell morphology abnormal, . NAMENDA dosage: 10 MG BID PO. During the same period patient was treated with ARICEPT, ACETAMINOPHEN, ZOLOFT, LOPRESSOR, LOMOTIL, NEXIUM, REGLAN, WELCHOL. Patient was hospitalized. Patient recovered.

Omalizumab Side Effects Report #5506589-3
OMALIZUMAB problem was reported by a Physician from UNITED STATES on Oct 29, 2007. Female patient, weighting 217.4 lb, was diagnosed with asthma and was treated with OMALIZUMAB. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, rash, . OMALIZUMAB dosage: unknown. During the same period patient was treated with PREDNISONE, FOSAMAX, POTASSIUM CHLORIDE, SINGULAIR. Patient recovered.

Tazocin Side Effects Report #5709319-5
Health Professional from JAPAN reported TAZOCIN problem on Apr 14, 2008. Female patient, weighting 121.3 lb, was diagnosed with cholecystitis, fluid replacement, nutritional support and was treated with TAZOCIN. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, interstitial lung disease, . TAZOCIN dosage: unknown. During the same period patient was treated with ELECTROLYTE SOLUTIONS, VITAMINS NOS, ASCORBIC ACID, RIBOFLAVIN, THIAMINE DISULFIDE, PYRIDOXINE HYDROCHLORIDE, VITAMIN B. Patient was hospitalized. Patient recovered.

Sinemet Side Effects Report #5328824-7
SINEMET problem was reported by a Physician from JAPAN on May 11, 2007. Male patient, 73 years of age, was diagnosed with parkinson's disease and was treated with SINEMET. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, erythema, . SINEMET dosage: unknown. During the same period patient was treated with TEGRETOL, BIOFERMIN, CABASER, LAXOBERON, CYANOCOBALAMIN, MUCOSOLVAN, MAGNESIUM OXIDE, TAKEPRON. Patient was hospitalized. Patient recovered.

Diovan Side Effects Report #5333233-0
Pharmacist from JAPAN reported DIOVAN problem on May 14, 2007. Male patient, 73 years of age, was treated with DIOVAN. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, . DIOVAN dosage: 80 MG/DAY. During the same period patient was treated with PURSENNID. Patient recovered.


Sinemet Side Effects Report #5334384-7
SINEMET problem was reported by a Physician from JAPAN on May 22, 2007. Male patient, 73 years of age, was diagnosed with parkinson's disease and was treated with SINEMET. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, erythema, . SINEMET dosage: unknown. During the same period patient was treated with TEGRETOL, BIOFERMIN, CABASER, LAXOBERON, CYANOCOBALAMIN, MUCOSOLVAN, MAGNESIUM OXIDE, TAKEPRON. Patient was hospitalized. Patient recovered.

Sinemet Side Effects Report #5305123-0
Physician from JAPAN reported SINEMET problem on Apr 11, 2007. Male patient, 73 years of age, was diagnosed with parkinson's disease and was treated with SINEMET. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, erythema, . SINEMET dosage: unknown. During the same period patient was treated with TEGRETOL, BIOFERMIN, CABASER, LAXOBERON, CYANOCOBALAMIN, MUCOSOLVAN, MAGNESIUM OXIDE, TAKEPRON. Patient was hospitalized. Patient recovered.

Delsym Side Effects Report #5309124-8
DELSYM problem was reported by a Physician from UNITED STATES on Mar 29, 2007. Female patient, 26 years of age, weighting 125.0 lb, was diagnosed with upper respiratory tract infection and was treated with DELSYM. After drug was administered, patient experienced the following problems/side effects: eosinophil percentage increased, pruritus, swelling face, throat irritation, throat tightness, . DELSYM dosage: unknown. During the same period patient was treated with NASONEX, TYLENOL. Patient recovered.

Xopenex Side Effects Report #5382913-X
Physician from UNITED STATES reported XOPENEX HFA problem on Feb 28, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX HFA. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lung neoplasm, lymphadenopathy mediastinal, lymphocyte percentage decreased, . XOPENEX HFA dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.

Xopenex Side Effects Report #5382913-X
XOPENEX HFA problem was reported by a Physician from UNITED STATES on Feb 28, 2007. Female patient, 74 years of age, weighting 162.0 lb, was diagnosed with chronic obstructive pulmonary disease and was treated with XOPENEX HFA. After drug was administered, patient experienced the following problems/side effects: chronic obstructive pulmonary disease, eosinophil percentage increased, haematocrit decreased, haemoglobin decreased, hilar lymphadenopathy, lung neoplasm, lymphadenopathy mediastinal, lymphocyte percentage decreased, . XOPENEX HFA dosage: unknown. During the same period patient was treated with CALCIUM CHLORIDE, ASPIRIN, PRILOSEC, TYLENOL, FORMOTEROL FUMARATE, ALBUTEROL, ATACAND, HYDROCHLOROTHIAZIDE. Patient was hospitalized. Patient recovered.


Escitalopram Side Effects Report #5324364-X
Health Professional from ITALY reported ESCITALOPRAM problem on Apr 24, 2007. Male patient, 75 years of age, was diagnosed with blunted affect, depressed mood and was treated with ESCITALOPRAM. After drug was administered, patient experienced the following problems/side effects: blood creatine phosphokinase increased, eosinophil percentage increased, haemoglobin decreased, lymphocyte percentage decreased, red blood cell count decreased, renal failure, . ESCITALOPRAM dosage: 5 MG QD PO. During the same period patient was treated with CARVEDILOL, AMIODAR, GLURENOR, OMEPRAZOLE, ZILORYC, BICARBONATE, LASIX. Patient recovered.

Lansoprazole Side Effects Report #5297439-1
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Apr 02, 2007. Male patient, 68 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, convulsion prophylaxis, staphylococcal infection and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: dyspnoea, eosinophil percentage increased, granulocytopenia, infection, inflammation, interstitial lung disease, lymphocyte stimulation test positive, pleural effusion, pyrexia, . LANSOPRAZOLE dosage: unknown. During the same period patient was treated with PHENOBAL, TARGOCID, LOXONIN, VASOLAN. Patient was hospitalized. Patient recovered.

Thalidomide Side Effects Report #5324212-8
Physician from UNITED KINGDOM reported THALIDOMIDE problem on Apr 12, 2007. Male patient, 60 years of age, was diagnosed with multiple myeloma and was treated with THALIDOMIDE. After drug was administered, patient experienced the following problems/side effects: arteriosclerosis, basophil percentage increased, eosinophil percentage increased, haematocrit decreased, haematocrit increased, haemoglobin decreased, haemoglobin increased, lymphocyte percentage decreased, mean cell haemoglobin decreased, . THALIDOMIDE dosage: 100 MG, ORAL. During the same period patient was treated with ASPIRIN, METOPROLOL TARTRATE, IMIDAPRIL, ISOSORBIDE MONONITRATE, VITAMIN, LACTULOSE, DULCOLAX, MELOXICAM. Patient recovered.

Lansoprazole Side Effects Report #5262641-1
LANSOPRAZOLE problem was reported by a Consumer or non-health professional from JAPAN on Mar 05, 2007. Male patient, 68 years of age, was diagnosed with prophylaxis against gastrointestinal ulcer, convulsion prophylaxis, device related infection, staphylococcal infection and was treated with LANSOPRAZOLE. After drug was administered, patient experienced the following problems/side effects: acute respiratory distress syndrome, eosinophil count increased, eosinophil percentage increased, granulocytopenia, interstitial lung disease, lymphocyte stimulation test positive, pleural effusion, pyrexia, respiratory failure, . LANSOPRAZOLE dosage: unknown. During the same period patient was treated with PHENOBARBITAL, TARGOCID, LOXONIN, VASOLAN. Patient was hospitalized. Patient recovered.